What is Vexev?
Headquartered in Surry Hills, Australia, Vexev is redefining the standards of clinical diagnostics through its next-generation imaging platforms. By integrating intelligent patient monitoring with non-invasive imaging techniques, the company addresses critical gaps in healthcare efficiency and patient outcomes. Vexev operates at the intersection of deep tech and medical science, positioning itself as a transformative force in the MedTech sector. Its market position is bolstered by a robust intellectual property portfolio and a clear focus on scalable, high-impact diagnostic solutions that cater to the evolving needs of modern healthcare providers.
How much funding has Vexev raised?
Vexev has raised a total of $6M across 1 funding round:
Other Financing Round
$6M
Other Financing Round (2026): $6M with participation from Ten13 Management, Horizon, Startmate, Neotribe Ventures, Blackbird Ventures, Bioshore Ventures, and Alumni Ventures
Key Investors in Vexev
Ten13 Management
An early-stage venture capital firm that leverages a network-driven approach to support technology-driven startups from pre-seed to Series A and beyond.
Startmate
A prominent mentor-driven accelerator and investment community in Australia and New Zealand that provides professional development and capital to ambitious founders.
Neotribe Ventures
A Silicon Valley-based venture capital firm that identifies and funds entrepreneurs developing breakthrough technologies with the potential to create transformative market movements.
What's next for Vexev?
With the infusion of $6M, Vexev is poised to transition into a phase of rapid commercialization and clinical validation. The strategic allocation of these funds will likely prioritize the expansion of its engineering teams and the acceleration of regulatory approval processes for its core imaging technologies. As the company scales, it will focus on deepening its integration within hospital networks and expanding its footprint in international markets. By leveraging its strong investor syndicate, Vexev aims to bridge the gap between laboratory innovation and bedside application, ultimately striving to reduce global healthcare costs while enhancing the precision of patient care.
See full Vexev company page
